Apollo Life Sciences (ASX:AOP) is a biotechnology company that has made major breakthroughs in the areas of drug delivery and expression of proteins from human cells. Apollo's combined technologies are expected to lead to more effective and lower cost therapeutics, compared to first generation protein-based drugs.

	Fax	(02) 9699 8615
	Principal Sector	Health & Pharm
	Principal Industry	Biotechnology
	Listed	2005/06/29
	Homepage	www.apollolifesciences.com/

Stock Exchange Stock Code   ASX:AOP AOP ZOBEX A3L

Apollo Life Science's Human Proteins Boost Stem Cell Growth Outperforming Other Products (NOV 16, 2006)

Apollo Life Sciences Begins Tests of Breakthrough Oral TNF Blocker for Arthritis (NOV 1, 2006)

Apollo Life Sciences Develops Topical Treatment for Psoriasis, Eliminating Need for Injections (OCT 17, 2006)

Diabetes Authority Applauds Australian "needle free" Treatment (SEP 25, 2006)

Apollo Life Sciences Announce Diabetes Breakthrough with Needle Free Treatment (SEP 25, 2006)

Bill Moss Invests $2 million in Apollo Life Sciences (MAR 7, 2006)

Apollo Life Sciences Produces New Range of Human Cell Protein Detection Kits (DEC 9, 2005)